Publicacions en què col·labora amb ALBERTO TEJEDOR JORGE (7)

2018

  1. Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity

    Journal of Lipid Research, Vol. 59, Núm. 9, pp. 1561-1574

2017

  1. Dual Internal Standards with Metals and Molecules for MALDI Imaging of Kidney Lipids

    Analytical Chemistry, Vol. 89, Núm. 23, pp. 12727-12734

  2. MALDI-LTQ-Orbitrap mass spectrometry imaging for lipidomic analysis in kidney under cisplatin chemotherapy

    Talanta, Vol. 164, pp. 16-26

2012

  1. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats

    Kidney International, Vol. 82, Núm. 6, pp. 652-663

  2. LA-ICP-MS and nHPLC-ESI-LTQ-FT-MS/MS for the analysis of cisplatin-protein complexes separated by two dimensional gel electrophoresis in biological samples

    Journal of Analytical Atomic Spectrometry, Vol. 27, Núm. 9, pp. 1474-1483

2011

  1. Elemental bioimaging in kidney by LA-ICP-MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies

    Analytical Chemistry, Vol. 83, Núm. 20, pp. 7933-7940

2010

  1. Cilastatin attenuates cisplatin-induced proximal tubular cell damage

    Journal of Pharmacology and Experimental Therapeutics, Vol. 334, Núm. 2, pp. 419-429